Showing results (791-800 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|September 4, 2021
The Challenges of Outcomes-Based Contract Implementation for Medicines in EuropeNatalie Bohm, Sarah Bermingham, Frank Grimsey Jones, et al.
Pharmacoeconomics|October 29, 2021
Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature ReviewThomas Ward, Ruben E Mujica-Mota, Anne E Spencer, et al.
Pharmacoeconomics|October 18, 2018
Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalJoanna Picot, Neelam Kalita, Wendy Gaisford, et al.
Pharmacoeconomics|June 19, 2026
Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review UpdateBenjamin P Geisler, Fredrik Holmboe, Irene Starinieri, et al.
Pharmacoeconomics|January 9, 2024
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted TherapyZakile A Mfumbilwa, Martijn J H G Simons, Bram Ramaekers, et al.
Pharmacoeconomics|July 13, 2026
Optimisation or Restriction? Unpacking the Logic Behind NICE DecisionsNadine Henderson, Brittany Darrow, Phill O'Neill, et al.
Pharmacoeconomics|July 14, 2026
Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical GuidanceJennifer D Zwicker, Ramesh Lamsal, Myla E Moretti, et al.
Pharmacoeconomics|September 24, 2019
Cooking Up a Transparent Model Following a DICE RecipeJörgen Möller
Pharmacoeconomics|August 4, 2026
External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without DiabetesFelice Gragnano, Martin Bøg, Anders Bo Bojesen, et al.
Pharmacoeconomics|July 22, 2026
Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic ReviewNuo Chen, Siyuan Wang, Jing Bai, et al.
Pageof 335